A Comparison of Clinical, Electro-Diagnostic, Laboratory, and Treatment Outcome Differences in a Cohort of HIV-Infected and HIV-Uninfected Patients With Myasthenia Gravis
In conclusion HIV-infected MG patients are more likely to require combination rescue therapy with PE/IVIG and IV cyclophosphamide compared with those who were HIV-uninfected. No side effects were documented in the HIV-infected group receiving the above therapy.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: African Health | Brain | India Health | Laboratory Medicine | Myasthenia Gravis | Neurology | Respiratory Medicine | Study